| Literature DB >> 31551709 |
Yunpeng Zhang1, Yaodong Zhang2, Danmei Chen1, Cuiting Wang1, Long Chen3, Chao Gao4, Wei Fan1, Jimin Shi1, Jihong Zhang1, Bing Li1.
Abstract
Cerebral palsy (CP) is a neurodevelopmental disorder usually occurring early in life and persisting through the whole life. Several risk factors, including perinatal hypoxia-ischemia (HI), may contribute to occurrence of CP in preterm infants. DNA hydroxymethylation has been shown to play an important role in neurodevelopment and neurodegenerative disorders. However, the effect of DNA hydroxymethylation in CP remains unknown. The aim of this study is to explore whether and how DNA hydroxymethylation is involved in CP pathogenesis. We observed that overall 5-hydroxymethylcytosine (5hmC) abundance in the cortex of the temporal lobe of rat pups was decreased significantly after hypoxic-ischemic injury, and the reduced expression of Tet1 and Tet2 enzymes might be responsible for this change. Identified differential hydroxymethylation regions (DhMRs) were richly involved in multiple signaling pathways related to neuronal development and function. Furthermore, we found that reduced 5hmC modification on the DhMRs-related genes were accompanied by decrease of their mRNA expression levels. These results suggest that 5hmC modifications are involved in the CP pathogenesis and may potentially serve as a new therapeutic target.Entities:
Keywords: 5-hydroxymethylcytosine; DNA hydroxymethylation; Tet; cerebral palsy; hypoxic-ischemic injury; neurodevelopment
Year: 2019 PMID: 31551709 PMCID: PMC6737274 DOI: 10.3389/fnmol.2019.00214
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 5.639
FIGURE 1Hypoxia-ischemia induced growth retardation and neurodevelopment deficits. (A) Experimental timeline. (B) Average body weight of control and hypoxic–ischemic pups measured from day 4 (P4) until the day 28 (i.e., 1 day after the hypoxic-ischemic interference, n = 8). (C) Mean righting reflex time of HI and control rats (n = 8). ∗P < 0.05, versus control group.
FIGURE 4(A) Genome-wide 5hmC reads density distribution. (B) Normalized 5hmC reads densities across TSS, TES, and RefSeq gene bodies. Gene bodies were normalized to 0–100% as relative positions. (C) Normalized 5hmC densities overlapping with known genomic features. Above the horizontal line is the P-value compared between the control group and the HI group.
FIGURE 2Hypoxia-ischemia impaired learning and memory functions of rat pups (n = 8). (A) Motion trails of two groups. (B) The average number of platform location crossings during the probe trial of MWM test. (C) The latency time of step-down test. (D) The errors number of step-down test. ∗∗∗P < 0.001, versus control group.
FIGURE 3Reduced 5hmC and Tet proteins level in HI rat cortex. (A) Representative dot blotting results of genomic 5hmC (n = 5). Methylene blue staining was used as a loading control. (B) Immunofluorescence staining with 5hmC antibody in the left temporal cortex (n = 5). 5hmC was labeled with Alexa Fluor 594 (red), and the neuron nuclei were labeled with DAPI (blue). The expression level of Tet1 (C) andTet2 (D) protein by western blotting (n = 6). ∗P < 0.05 versus control group.
FIGURE 5Identification and characterization of differentially hydroxymethylated regions (DhMRs) in hypoxic-ischemic rat models. (A) Chromosome circular map of genome-wide DhMRs. (B) Identification of 1892 hypo-DhMRs. (C) Identification of 1169 hyper-DhMRs. (D) Annotation of DhMRs to various genomic features.
FIGURE 6Gene oncology analyses for DhMRs. (A) Top 10 GO biological processes associated with hypo-DhMRs-associated genes. (B) Top 10 GO BPs associated with hyper-DhMRs-associated genes. (C) RT-PCR analysis of the mRNA levels of selected hypo-DhMRs related genes in control and HI rats. β-Actin was used as a control. ∗P < 0.05, versus control group.